PointState Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$240M |
| 2 |
CRH
CRH
|
+$192M |
| 3 |
Illumina
ILMN
|
+$186M |
| 4 |
Ulta Beauty
ULTA
|
+$143M |
| 5 |
Capital One
COF
|
+$136M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$201M |
| 2 |
Apollo Global Management
APO
|
+$142M |
| 3 |
Broadcom
AVGO
|
+$113M |
| 4 |
Live Nation Entertainment
LYV
|
+$103M |
| 5 |
Core & Main
CNM
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 19.95% |
| 2 | Consumer Discretionary | 17.72% |
| 3 | Financials | 15.91% |
| 4 | Healthcare | 12.13% |
| 5 | Technology | 11.99% |
Similar funds
PointState Capital's Q4 2024 Portfolio in Review
As of Q4 2024, PointState Capital held 67 positions worth $5.49B, down 0.47% from $5.51B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
PointState Capital deployed $360M of net new capital in Q4 2024, opening 14 new positions and adding to 17 existing holdings. Its largest new stake was Charles Schwab: 3,206,059 shares worth $237M.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, down from 35% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Marvell Technology, an estimated $201M trimmed.
- PointState Capital's largest Q4 2024 buy was Charles Schwab: 3,206,059 shares worth $237M.
- PointState Capital added most to CRH in Q4 2024, an estimated $192M increase.
- PointState Capital's biggest Q4 2024 reduction was Marvell Technology, cutting an estimated $201M.
- PointState Capital fully exited Broadcom in Q4 2024, selling an estimated $113M.
- PointState Capital's ten largest holdings make up 49% of its $5.49B portfolio in Q4 2024.
- PointState Capital opened 14 new positions and closed 17 in Q4 2024.
- PointState Capital's portfolio value fell 0.47% quarter-over-quarter to $5.49B.
Based on PointState Capital's 13F filing for Q4 2024, filed 14 Feb 2025.